XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Cash and cash equivalents    
Restricted cash $ 169 $ 427
Accumulated depreciation and amortization 12,039 10,739
Other assets, reserves for credit losses 86 27
Liabilities    
Long-term debt $ 56,387 $ 49,715
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares, authorized (in shares) 20,000,000 20,000,000
Preferred shares, issued (in shares) 1,600 1,600
Preferred shares, outstanding (in shares) 1,600 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized (in shares) 3,600,000,000 3,600,000,000
Common shares, issued (in shares) 686,000,000 702,000,000
Common shares, outstanding (in shares) 686,000,000 702,000,000
Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross $ 62,031 $ 59,411
Allowance for credit losses 180 171
Card Member loans    
Cash and cash equivalents    
Financing receivables, gross 151,832 139,674
Allowance for credit losses 5,909 5,679
Other loans    
Cash and cash equivalents    
Financing receivables, gross 10,928 9,232
Allowance for credit losses 323 194
Variable Interest Entity, Primary Beneficiary    
Cash and cash equivalents    
Restricted cash 0 6
Restricted investments 84 82
Liabilities    
Long-term debt 13,022 13,880
Variable Interest Entity, Primary Beneficiary | Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross 5,659 3,927
Variable Interest Entity, Primary Beneficiary | Card Member loans    
Cash and cash equivalents    
Financing receivables, gross $ 27,719 $ 28,278